Medication persistence rates and factors associated with persistence in patients following stroke: A cohort study

BMC Neurology

Volumn 8, Issue , 2008, Pages

  Lummis, Heather L ^a   Sketris, Ingrid S ^b   Gubitz, Gordon J ^b   Joffres, Michel R ^c   Flowerdew, Gordon J ^b  

^a Capital District Health Authority   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

^c SIMON FRASER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; FIBRINOLYTIC AGENT;

AGED; ARTICLE; CANADA; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; DRUG COST; DRUG USE; DYSLIPIDEMIA; FEMALE; HIGH RISK PATIENT; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; HYPERGLYCEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRESCRIPTION; RISK ASSESSMENT; SELF REPORT; THROMBOSIS; TREATMENT OUTCOME; AGE; DISABLED PERSON; ECONOMICS; MULTIVARIATE ANALYSIS; PSYCHOLOGICAL ASPECT; STATISTICAL MODEL; STATISTICS; STROKE;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; COHORT STUDIES; DISABLED PERSONS; DRUG COSTS; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; LOGISTIC MODELS; MALE; MULTIVARIATE ANALYSIS; NOVA SCOTIA; PATIENT COMPLIANCE; STROKE;

EID: 48249088061     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/1471-2377-8-25     Document Type: Article

References (47)

1. The Atlas of Heart Disease and Stroke http://www.who.int/ cardiovascular_diseases/resources/atlas/en/
2. Wolf PA Clagett GP Easton JD Goldstein LB Gorelick PB Kelly-Hayes M Sacco RL Whisnant JP Preventing ischemic stroke in patients with prior stroke and transient ischemic attack: A statement for healthcare professionals from the Stroke Council of the American Heart Association Stroke 1999, 30(9):1991-1994. 10471455
3. Redfern J McKevitt C Rudd AG Wolfe CD Health care follow-up after stroke: Opportunities for secondary prevention Fam Pract 2002, 19(4):378-382. 10.1093/fampra/19.4.378 12110559
4. Qureshi AI Suri MF Guterman LR Hopkins LN Ineffective secondary prevention in survivors of cardiovascular events in the US population: report from the Third National Health and Nutrition Examination Survey Arch Intern Med 2001, 161(13):1621-1628. 10.1001/archinte.161.13.1621 11434794
5. Filippi A Bignamini AA Sessa E Samani F Mazzaglia G Secondary prevention of stroke in Italy: A cross-sectional survey in family practice Stroke 2003, 34(4):1010-1014. 10.1161/01.STR.0000062888.90293.AA 12637698
6. Saxena R Koudstaal PJ Anticoagulants for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischaemic attack Cochrane Database Syst Rev 2004, 2:CD000185. 15106146
7. Hart RG Benavente O McBride R Pearce LA Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: A meta-analysis Ann Intern Med 1999, 131(7):492-501. 10507957
8. Antithrombotic Trialists' Collaboration Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death myocardial infarction and stroke in high risk patients BMJ 2002, 324(7329):71-86. 64503 11786451
9. Lawes CM Bennett DA Feigin VL Rodgers A Blood pressure and stroke: An overview of published reviews Stroke 2004, 35(3):776-785. 10.1161/ 01.STR.0000116869.64771.5A 14976329
10. Stroke Council, American Heart Association., American Stroke Association Statins after ischemic stroke and transient ischemic attack: An advisory statement from the Stroke Council American Heart Association and American Stroke Association Stroke 2004, 35(4):1023. 15044812
11. Corvol JC Bouzamondo A Sirol M Hulot JS Sanchez P Lechat P Differential effects of lipid-lowering therapies on stroke prevention: A meta-analysis of randomized trials Arch Intern Med 2003, 163(6):669-676. 10.1001/archinte.163.6.669 12639199
12. Rashid P Leonardi-Bee J Bath P Blood pressure reduction and secondary prevention of stroke and other vascular events: A systematic review Stroke 2003, 34(11):2741-2748. 10.1161/01.STR.0000092488.40085.15 14576382
13. Gueyffier F Boissel JP Boutitie F Pocock S Coope J Cutler J Ekbom T Fagard R Friedman L Kerlikowske K Perry M Prineas R Schron E Effect of antihypertensive treatment in patients having already suffered from stroke Gathering the evidence The INDANA (INdividual Data ANalysis of Antihypertensive intervention trials) Project Collaborators Stroke 1997, 28(12):2557-2562. 9412649
14. World Health Organisation Adherence to Long-Term Therapies:EVidence for Action Geneva: WHO 2003
15. Hughes CM Medication non-adherence in the elderly: How big is the problem? Drugs Aging 2004, 21(12):793-811. 10.2165/ 00002512-200421120-00004 15382959
16. Colivicchi F Bassi A Santini M Caltagirone C Discontinuation of statin therapy and clinical outcome after ischemic stroke Stroke 2007, 38(10):2652-2657. 10.1161/STROKEAHA.107.487017 17761916
17. Hillen T Dundas R Lawrence E Stewart JA Rudd AG Wolfe CD Antithrombotic and antihypertensive management 3 months after ischemic stroke: A prospective study in an inner city population Stroke 2000, 31(2):469-475. 10657424
18. Hamann GF Weimar C Glahn J Busse O Diener HC German Stroke Data Bank Adherence to secondary stroke prevention strategies-results from the German Stroke Data Bank Cerebrovasc Dis 2003, 15(4):282-288. 10.1159/ 000069490 12686793
19. Sappok T Faulstich A Stuckert E Kruck H Marx P Koennecke HC Compliance with secondary prevention of ischemic stroke: A prospective evaluation Stroke 2001, 32(8):1884-1889. 11486121
20. Ovbiagele B Saver JL Fredieu A Suzuki S Selco S Rajajee V McNair N Razinia T Kidwell CS In-hospital initiation of secondary stroke prevention therapies yields high rates of adherence at follow-up Stroke 2004, 35(12):2879-2883. 10.1161/01.STR.0000147967.49567.d6 15514170
21. Shaya FT El Khoury AC Mullins CD Du D Skolasky R Fatodu H Garber H Weir MR Drug therapy persistence and stroke recurrence Am J Manag Care 2006, 12(6);313-319. 16756450
22. Phillips SJ Eskes GA Gubitz GJ Queen Elizabeth II Health Sciences Centre Acute Stroke Team Description and evaluation of an acute stroke unit CMAJ 2002, 167(6):655-660. 122030 12358201
23. Bamford JM Sandercock PA Warlow CP Slattery J Interobserver agreement for the assessment of handicap in stroke patients Stroke 1989, 20(6):828. 2728057
24. Bamford J Sandercock P Dennis M Burn J Warlow C Classification and natural history of clinically identifiable subtypes of cerebral infarction Lancet 1991, 337(8756):1521-1526. 10.1016/ 0140-6736(91)93206-O 1675378
25. The EC/IC Bypass Study group The international cooperative study of extracranial/intracranial arterial anastomosis (EC/IC bypass study): methodology and entry characteristics Stroke 1985, 16(3);397-406. 2860739
26. Mahoney FI Barthel DW Functional evaluation: The Barthel index Md State Med J 1965, 14:61-65. 14258950
27. Kiernan RJ Mueller J Langston JW Van Dyke C The neurobehavioral cognitive status examination: A brief but quantitative approach to cognitive assessment Ann Intern Med 1987, 107(4):481-485. 3631786
28. van Swieten JC Koudstaal PJ Visser MC Schouten HJ van Gijn J Interobserver agreement for the assessment of handicap in stroke patients Stroke 1988, 19(5):604-607. 3363593
29. Yesavage JA Brink TL Rose TL Lum O Huang V Adey M Leirer VO Development and validation of a geriatric depression screening scale: A preliminary report J Psychiatr Res 1982, 17(1):37-49. 10.1016/0022-3956(82)90033-4 7183759
30. Reisberg B Ferris SH de Leon MJ Crook T The global deterioration scale for assessment of primary degenerative dementia Am J Psychiatry 1982, 139(9):1136-1139. 7114305
31. The ATC/DDD System http://www.whocc.no/atcddd/
32. Atlantic Pharmaceutical Services Incorporated APSI Pricing Guide Halifax Nova Scotia: Atlantic Pharmaceutical Services Incorporated 2005
33. Total Pricing Systems PPS Pharma Publication Saint John New Brunswick 2002
34. Total Pricing Systems PPS Pharma Publication Saint John New Brunswick 2000
35. Canadian Institute for Health Information Canadian Coding Standards for ICD-10-CA and CCI for 2006 Ottawa ON: Canadian Institutes for Health Information 2005
36. Population Health Research Unit http://www.phru.dal.ca
37. Aronow HD Novaro GM Lauer MS Brennan DM Lincoff AM Topol EJ Kereiakes DJ Nissen SE In-hospital initiation of lipid-lowering therapy after coronary intervention as a predictor of long-term utilization: A propensity analysis Arch Intern Med 2003, 163(21):2576-2582. 10.1001/ archinte.163.21.2576 14638557
38. Stroke Unit Trialists Collaboration How do stroke units improve patient outcomes? A collaborative systematic review of the randomized trials Stroke 1997, 28(11);2139-2144. 9368554
39. Shalansky SJ Levy AR Effect of number of medications on cardiovascular therapy adherence Ann Pharmacother 2002, 36(10):1532-1539. 10.1345/ aph.1C044 12243601
40. Grant RW O'Leary KM Weilburg JB Singer DE Meigs JB Impact of concurrent medication use on statin adherence and refill persistence Arch Intern Med 2004, 164(21):2343-2348. 10.1001/archinte.164.21.2343 15557413
41. Nova Scotia Pharmacare http://www.gov.ns.ca/health/Pharmacare/ seniors_pharmacare/seniors_pharmacare.asp
42. Heart and Stroke Foundation of Canada The Growing Burden of Heart Disease and Stroke in Canada 2003 Ottawa Canada 2003
43. Whelan AM Cooke CA Sketris IS The impact of socioeconomic and demographic factors on the utilization of smoking cessation medications in patients hospitalized with cardiovascular disease in Nova Scotia Canada J Clin Pharm Ther 2005, 30(2):165-171. 10.1111/ j.1365-2710.2004.00622.x 15811170
44. Gold DT Medication adherence: A challenge for patients with postmenopausal osteoporosis and other chronic illnesses J Manag Care Pharm 2006, 12(6 Suppl A):S20-5. quiz S26-8 17269854
45. Kwon A Bungay KM Pei Y Rogers WH Wilson IB Zhou Q Adler DA Antidepressant use: Concordance between self-report and claims records Med Care 2003, 41(3):368-374. 10.1097/00005650-200303000-00005 12618640
46. Saunders K Simon G Bush T Grothaus L Assessing the feasibility of using computerized pharmacy refill data to monitor antidepressant treatment on a population basis: A comparison of automated and self-report data J Clin Epidemiol 1998, 51(10):883-890. 10.1016/S0895-4356(98)00053-5 9762882
47. Sjahid SI Linden van der PD Stricker BH Agreement between the pharmacy medication history and patient interview for cardiovascular drugs: The Rotterdam elderly study Br J Clin Pharmacol 1998, 45(6):591-595. 1873642 9663815 10.1046/j.1365-2125.1998.00716.x